Etomidate

United States Anesthesia Drugs Research Report 2024-2030 with Company Analysis of Baxter International, Abbvie, Medtronic, Draegerwerk, Koninklijke Philips, and Abbott Laboratories - ResearchAndMarkets.com

Retrieved on: 
Monday, March 11, 2024
Other Consumer, Manufacturing, Other Science, Pharmaceutical, Medical Devices, Hospitals, Consumer, Science, Practice Management, Dental, Managed Care, Medical Supplies, Biotechnology, Surgery, Health, Health Technology, Chemicals, Plastics, Health Insurance, Etomidate, Prevalence, Barbiturate, Isoflurane, Conditional sentence, Patient, Ache, Desflurane, National Cancer Institute, Anesthesiology, Local anesthesia, Health Canada, Survivor, Nitrous oxide, Lidocaine, Society, Cancer, Safety, Plastic, Benzocaine, Anesthetic vaporizer, Dentistry

The "United States Anesthesia Drugs Market, Size, Forecast 2024-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "United States Anesthesia Drugs Market, Size, Forecast 2024-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • The demand for anesthesia medicines is rising because of the growing number of surgeries and the approval of recent anesthesia drugs.
  • The United States Anesthesia Drugs Market is assessed into Inhalation Anesthesia, Intravenous Anesthesia, and Local Anesthesia.
  • The General Anesthesia Drugs Market is hastily advancing, specifically in the use of Sevoflurane, Desflurane, Isoflurane, and other inhalation anesthesia drugs.

United States Anesthesia Drugs Market, Size, Forecast Report 2022-2027: Industry Trends, Share, Growth, Impact of COVID-19, Opportunities, Company Analysis - ResearchAndMarkets.com

Retrieved on: 
Wednesday, February 9, 2022
Health, Pharmaceutical, Policy, Blue Shield, Hypokinesia, Anesthetic, Isoflurane, Medicare, Medicine, Sevoflurane, Unconsciousness, Time, US, Benzodiazepine, Incidence, Methohexital, Fentanyl, COVID-19, Hospital, Bupivacaine, Brain, Etomidate, Analgesic, Anthem (company), Desflurane, Endo International, Drug, CAGR, Baxter International, Pharmaceutical industry, Propofol, Anesthesia, Ketamine, AbbVie, Growth, Pentobarbital

The "United States Anesthesia Drugs Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "United States Anesthesia Drugs Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • United States Anesthesia Drugs Market will reach US$ 6.2 Billion by 2027 from $4.9 Billion in 2021, growing at a CAGR of 4%.
  • Covid-19 Impact on the United States Anesthesia Drugs Industry:
    The COVID-19 pandemic has significantly affected the United States anesthesia drugs market.
  • On the basis of type, United States anesthesia drugs market includes General Inhalation Anesthesia Drugs market, General Intravenous Anesthesia Drugs Market and Local Anesthesia Drugs Market.